Purchases and Sales Made in Q4 2023 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q4 2023. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
- |
-42.7K- 68.89% |
$1.09M - $1.58M
|
19.3K
$582K
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-45.1K- 7.67% |
$1.16M - $1.67M
|
543K
$16.4M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-46.1K- 54.3% |
$1.18M - $1.71M
|
38.8K
$1.17M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-51.5K- 68.48% |
$1.32M - $1.91M
|
23.7K
$714K
|
|
|
Feb 14, 2024
Q4 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-62.5K- 16.89% |
$1.6M - $2.32M
|
308K
$9.27M
|
|
|
Feb 14, 2024
Q4 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-81K- 13.28% |
$2.08M - $3M
|
529K
$16M
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-84.9K- 11.4% |
$2.18M - $3.15M
|
660K
$19.9M
|
|
|
Feb 02, 2024
Q4 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-86.8K- 78.68% |
$2.22M - $3.22M
|
23.5K
$710K
|
|
|
Feb 14, 2024
Q4 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-92.3K- 1.8% |
$2.37M - $3.42M
|
5.04M
$152M
|
|
|
Oct 07, 2024
Q4 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-111K- 12.46% |
$2.83M - $4.1M
|
777K
$23.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-113K- 14.19% |
$2.88M - $4.17M
|
680K
$20.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-136K- 85.69% |
$3.5M - $5.06M
|
22.8K
$687K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-152K- 92.85% |
$3.89M - $5.63M
|
11.7K
$353K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-166K- 38.13% |
$4.25M - $6.15M
|
269K
$8.12M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-190K- 22.7% |
$4.88M - $7.06M
|
648K
$19.6M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-193K- 67.44% |
$4.94M - $7.15M
|
93.1K
$2.81M
|
|
|
Feb 14, 2024
Q4 2023
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-197K- 75.19% |
$5.05M - $7.3M
|
65K
$1.96M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-209K- 51.96% |
$5.35M - $7.74M
|
193K
$5.82M
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-210K- 75.72% |
$5.38M - $7.78M
|
67.3K
$2.03M
|
|
|
Feb 14, 2024
Q4 2023
|
Saturn V Capital Management LLC
Austin, TX |
SELL
|
- |
-339K- 30.13% |
$8.7M - $12.6M
|
787K
$23.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-808K- 19.13% |
$20.7M - $30M
|
3.42M
$103M
|
|
|
Feb 14, 2024
Q4 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-1.19M- 75.0% |
$30.6M - $44.2M
|
397K
$12M
|
|
|
Feb 14, 2024
Q4 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.23M- 42.43% |
$31.5M - $45.5M
|
1.67M
$50.3M
|